Dmitry Balyasny’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $103M | Buy |
2,405,640
+1,571,860
| +189% | +$70.2M | 0.13% | 183 |
|
|
2026
Q1 | $40.2M | Buy |
+833,780
| New | +$38.9M | 0.05% | 414 |
|
|
2025
Q4 | – | Sell |
-484,036
| Closed | -$22.8M | – | 3516 |
|
|
2025
Q3 | $22.8M | Buy |
+484,036
| New | +$23.4M | 0.03% | 658 |
|
|
2025
Q1 | – | Sell |
-71,094
| Closed | -$3.43M | – | 3246 |
|
|
2024
Q4 | $3.43M | Sell |
71,094
-600,655
| -89% | -$30.5M | 0.01% | 1453 |
|
|
2024
Q3 | $38.7M | Sell |
671,749
-189,844
| -22% | -$10.2M | 0.06% | 391 |
|
|
2024
Q2 | $41.8M | Buy |
+861,593
| New | +$41.6M | 0.07% | 340 |
|
|
2024
Q1 | – | Sell |
-131,715
| Closed | -$6.55M | – | 3086 |
|
|
2023
Q4 | $6.55M | Buy |
+131,715
| New | +$6.44M | 0.01% | 1027 |
|
|
2023
Q3 | – | Sell |
-390,465
| Closed | -$21M | – | 2696 |
|
|
2023
Q2 | $21M | Buy |
+390,465
| New | +$21M | 0.05% | 511 |
|
|
2023
Q1 | – | Sell |
-170,745
| Closed | -$8.27M | – | 3115 |
|
|
2022
Q4 | $8.27M | Sell |
170,745
-133,175
| -44% | -$5.85M | 0.02% | 812 |
|
|
2022
Q3 | $11.6M | Buy |
+303,920
| New | +$13.5M | 0.04% | 621 |
|
|
2021
Q4 | – | Sell |
-223,815
| Closed | -$10.8M | – | 2570 |
|
|
2021
Q3 | $10.8M | Buy |
223,815
+168,884
| +307% | +$8.59M | 0.04% | 546 |
|
|
2021
Q2 | $2.89M | Buy |
+54,931
| New | +$2.87M | 0.01% | 899 |
|
|
2020
Q4 | – | Sell |
-261,540
| Closed | -$13.1M | – | 1674 |
|
|
2020
Q3 | $13.1M | Sell |
261,540
-89,014
| -25% | -$4.58M | 0.1% | 311 |
|
|
2020
Q2 | $17.9M | Sell |
350,554
-299,538
| -46% | -$14.6M | 0.16% | 198 |
|
|
2020
Q1 | $28.4M | Buy |
650,092
+6,818
| +1% | +$326K | 0.34% | 70 |
|
|
2019
Q4 | $32.3M | Sell |
643,274
-67,691
| -10% | -$3.17M | 0.19% | 156 |
|
|
2019
Q3 | $32.9M | Buy |
710,965
+447,590
| +170% | +$19.3M | 0.23% | 122 |
|
|
2019
Q2 | $11.4M | Sell |
263,375
-48,667
| -16% | -$2.07M | 0.07% | 369 |
|
|
2019
Q1 | $13.8M | Buy |
312,042
+115,127
| +58% | +$4.93M | 0.09% | 309 |
|
|
2018
Q4 | $8.55M | Buy |
196,915
+13,017
| +7% | +$574K | 0.06% | 383 |
|
|
2018
Q3 | $8.21M | Buy |
+183,898
| New | +$7.86M | 0.04% | 546 |
|
|
2018
Q1 | – | Sell |
-1,590,248
| Closed | -$66.2M | – | 2281 |
|
|
2017
Q4 | $68.4M | Buy |
1,590,248
+291,621
| +22% | +$13.4M | 0.21% | 111 |
|
|
2017
Q3 | $64.7M | Sell |
1,298,627
-1,198,886
| -48% | -$58M | 0.25% | 96 |
|
|
2017
Q2 | $120M | Buy |
2,497,513
+591,785
| +31% | +$28.3M | 0.49% | 30 |
|
|
2017
Q1 | $86.2M | Buy |
1,905,728
+1,123,302
| +144% | +$47.7M | 0.4% | 46 |
|
|
2016
Q4 | $31.6M | Buy |
+782,426
| New | +$30.8M | 0.17% | 158 |
|
|
2016
Q2 | – | Sell |
-92,522
| Closed | -$3.79M | – | 1425 |
|
|
2016
Q1 | $3.72M | Sell |
92,522
-371,322
| -80% | -$14.9M | 0.02% | 602 |
|
|
2015
Q4 | $19.8M | Buy |
+463,844
| New | +$21.3M | 0.14% | 207 |
|
Other funds holding SNY
MIP
BIP
Dmitry Balyasny's SNY Position: Q2 2026 in Review
Dmitry Balyasny increased its Sanofi (SNY) stake by 189% in Q2 2026, buying an estimated $70.2M and bringing the position to 2,405,640 shares worth $103M. The position accounts for 0.13% of the portfolio, ranked #183.
Dmitry Balyasny first reported a position in SNY in Q4 2015 and has held it in 28 quarters since. The position peaked at $120M in Q2 2017. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Dmitry Balyasny held 2,405,640 shares of Sanofi worth $103M as of Q2 2026.
- Dmitry Balyasny bought 1,571,860 Sanofi shares in Q2 2026, an estimated $70.2M.
- Sanofi made up 0.13% of Dmitry Balyasny's portfolio in Q2 2026, its #183 holding.
- Dmitry Balyasny first reported a position in Sanofi in Q4 2015 and has held it in 28 quarters since.
- Dmitry Balyasny's Sanofi position peaked at $120M in Q2 2017.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.